Fears Over Medicine Sales In Dutch Supermarkets

11 November 1997

Around 70% of supermarkets in the Netherlands are willing to sellprescription drugs, according to a survey of the sector conducted by the professional magazine Distrifood. It is proposed that, under certain circumstances, supermarkets will be allowed to sell prescription drugs starting next year, and this could well lead to competition with pharmacies. One condition, however, is that a pharmacist has to be present in the store.

Participants in the survey expected prices to come down as soon as drugs are sold in supermarkets. Moreover, because of longer opening hours and weekend trading, supermarkets may gain significant market share. Sales of drugs may be important because of the attractive 40% margins, according to Distrifood. Dutch supermarkets are said to be following closely developments in Germany, where drugs are already selling in supermarkets.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight